BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 32102528)

  • 1. Factors Affecting Long-Survival of Patients with Breast Cancer by Non-Mixture and Mixture Cure Models Using the Weibull, Log-logistic and Dagum Distributions: A Bayesian Approach.
    Rafati S; Baneshi MR; Bahrampour A
    Asian Pac J Cancer Prev; 2020 Feb; 21(2):485-490. PubMed ID: 32102528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determining the Factors Affecting Long-Term and Short-Term Survival of Breast Cancer Patients in Rafsanjan Using a Mixture Cure Model.
    Jahani S; Hoseini M; Pourhamid R; Askari M; Moslemi A
    J Res Health Sci; 2021 May; 21(2):e00516. PubMed ID: 34465639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Weibull and Lognormal Cure Models with Cox in the Survival Analysis Of Breast Cancer Patients in Rafsanjan.
    Hoseini M; Bahrampour A; Mirzaee M
    J Res Health Sci; 2017 Feb; 17(1):e00369. PubMed ID: 28413171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring factors related to metastasis free survival in breast cancer patients using Bayesian cure models.
    Jafari-Koshki T; Mansourian M; Mokarian F
    Asian Pac J Cancer Prev; 2014; 15(22):9673-8. PubMed ID: 25520087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of accelerated failure time models for breast cancer patients' survival in Kurdistan Province of Iran.
    Karimi A; Delpisheh A; Sayehmiri K
    J Cancer Res Ther; 2016; 12(3):1184-1188. PubMed ID: 28054533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fitting Cure Rate Model to Breast Cancer Data of Cancer Research Center.
    Baghestani AR; Zayeri F; Akbari ME; Shojaee L; Khadembashi N; Shahmirzalou P
    Asian Pac J Cancer Prev; 2015; 16(17):7923-7. PubMed ID: 26625822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival probability and prognostic factors of Iranian breast cancer patients using cure rate model.
    Meshkat M; Baghestani AR; Zayeri F; Khayamzadeh M; Akbari ME
    Breast J; 2018 Nov; 24(6):1015-1018. PubMed ID: 30270522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison Cure Rate Models by DIC Criteria in Breast Cancer Data.
    Baghestani AR; Shahmirzalou P; Sayad S; Akbari ME; Zayeri F
    Asian Pac J Cancer Prev; 2018 Jun; 19(6):1601-1606. PubMed ID: 29936785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation of the cure rate in Iranian breast cancer patients.
    Rahimzadeh M; Baghestani AR; Gohari MR; Pourhoseingholi MA
    Asian Pac J Cancer Prev; 2014; 15(12):4839-42. PubMed ID: 24998549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of a Non-Mixture Cure Rate Model for Analyzing Survival of Patients with Breast Cancer.
    Baghestani AR; Moghaddam SS; Majd HA; Akbari ME; Nafissi N; Gohari K
    Asian Pac J Cancer Prev; 2015; 16(16):7359-63. PubMed ID: 26514537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of prognostic factors in long-term survival of male and female patients with colorectal cancer using non-mixture cure model based on the Weibull distribution.
    Azizmohammad Looha M; Zarean E; Masaebi F; Pourhoseingholi MA; Zali MR
    Surg Oncol; 2021 Sep; 38():101562. PubMed ID: 33862578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of breast cancer survival among young, middle-aged, and elderly patients in southern Iran using Cox and empirical Bayesian additive hazard models.
    Nematolahi S; Ayatollahi SMT
    Epidemiol Health; 2017; 39():e2017043. PubMed ID: 29056033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Factors of Breast Cancer Survival in the Islamic Republic of Iran: an Additive Empirical Bayesian Approach.
    Nematolahi S; Rezaianzadeh A; Zare N; Akrami M; Tahmasebi S
    East Mediterr Health J; 2018 Jan; 23(11):721-728. PubMed ID: 29319143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current estimates of the cure fraction: a feasibility study of statistical cure for breast and colorectal cancer.
    Stedman MR; Feuer EJ; Mariotto AB
    J Natl Cancer Inst Monogr; 2014 Nov; 2014(49):244-54. PubMed ID: 25417238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cure models for estimating hospital-based breast cancer survival.
    Rama R; Swaminathan R; Venkatesan P
    Asian Pac J Cancer Prev; 2010; 11(2):387-91. PubMed ID: 20843121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling of breast cancer prognostic factors using a parametric log-logistic model in Fars province, Southern Iran.
    Zare N; Doostfatemeh M; Rezaianzadeh A
    Asian Pac J Cancer Prev; 2012; 13(4):1533-7. PubMed ID: 22799361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of Cox and Parametric Survival Models to Assess Social Determinants of Health Affecting Three-Year Survival of Breast Cancer Patients.
    Mohseny M; Amanpour F; Mosavi-Jarrahi A; Jafari H; Moradi-Joo M; Davoudi Monfared E
    Asian Pac J Cancer Prev; 2016; 17(S3):311-6. PubMed ID: 27165244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of a non-parametric non-mixture cure rate model for analyzing the survival of patients with colorectal cancer in Iran.
    Azizmohammad Looha M; Pourhoseingholi MA; Nasserinejad M; Najafimehr H; Zali MR
    Epidemiol Health; 2018; 40():e2018045. PubMed ID: 30220192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statistical estimates from black non-Hispanic female breast cancer data.
    Khan HM; Ibrahimou B; Saxena A; Gabbidon K; Abdool-Ghany F; Ramamoorthy V; Ullah D; Stewart TS
    Asian Pac J Cancer Prev; 2014; 15(19):8371-6. PubMed ID: 25339031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors Affecting Long-Survival of Patients with Esophageal Cancer Using Non-Mixture Cure Fraction Model.
    Zarean E; Azizmohammad Looha M; Amini P; Mahmoudi M; Azimi T
    Asian Pac J Cancer Prev; 2018 Jun; 19(6):1677-1683. PubMed ID: 29938465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.